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Abstract
Background: Health-related quality of life (HRQoL) and health preference of patients with diabetes mellitus (DM)
are essential in health economic evaluations but data on Chinese population is rare. This study aims to evaluate
HRQoL and health preference of diabetic patients with different diabetic complications in Chinese population.
Methods: A cross-sectional study was conducted in 1275 patients with DM, including 518 subjects with various
DM-related complications. HRQoL and health preference were estimated using SF-12 and SF-6D questionnaires,
respectively. Disease status of DM and complications were identified from documented clinical diagnosis.
Multivariable regression was used to investigate the effects of specific complications on HRQoL and health
preference, adjusting for socio-demographic and clinical parameters.
Results: The presence of any diabetic complication was associated with lower physical component summary (−3.81
points, P < 0.01), and end-stage renal disease (ESRD) showed greatest reduction (−7.05 points, P < 0.01). Mental
component summary and mental health (MH) scores were not decreased in any of the diabetic complications. The
health preference score for diabetic subjects without complications was 0.882 (95% CI, 0.778 to 0.989). The
reductions of health preference score were significant for stroke (−0.042, 95% CI -0.072 to −0.012), ESRD (−0.055,
95% CI -0.093 to −0.017), and sight-threatening diabetic retinopathy (STDR) (−0.043, 95% CI -0.075 to −0.010), while
heart disease had an insignificant reduction (−0.017, 95% CI -0.042 to 0.008).
Conclusions: The presence of any of the four major diabetic complications (heart disease, stroke, ESRD and STDR)
was associated with lower HRQoL and health preference scores. Findings of this study facilitated the cost-
effectiveness studies of alternative management strategies for prevention of diabetic complications in Chinese
population.
Keywords: Diabetes mellitus, Health-related quality of life, Health preference, Heart disease, Stroke, Microvascular
complications
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Background
Diabetes mellitus (DM) is highly prevalent and incident
chronic disease worldwide [1]. The number of diabetic
patients in China had reached 98 million in 2013, ac-
counting for a quarter of the total diabetic patients in
the world [2]. With the substantial prolonging life ex-
pectancy in DM [3], health-related quality of life
(HRQoL) is increasingly recognized as an important out-
come of chronic disease, reflecting the subjective impact
of a disease condition and related interventions on
patient-reported outcomes. The effectiveness of an inter-
vention on medical outcomes might be of interest to
health care providers; however, from the patients’ view-
point, outcomes are meaningful only if they can feel the
positive changes in physical, emotional and social
wellbeing, that is, health-related quality of life [4]. The
self-perception of changes in HRQoL can also motivate
patients to engage in DM self-management [4].
HRQoL is a useful tool in health outcomes research
and health technology assessment. In the economic
evaluation of DM management, quality-adjusted life
years (QALYs) is a commonly used outcome measure to
evaluate the effectiveness of the intervention in man-
aging DM and its complications. QALYs are estimated
by multiplying the number of years subjects spend in a
particular health state by a preference weight associated
with that health state, which was known as health pref-
erence. Health preference could be estimated by both
direct and indirect methods. The direct methods were
trials that ask subjects to score their preference for the
specific health states, and included standard Gamble and
time trade-off. Health preference could also be estimated
by indirect methods, which ask subjects to define the
health states they experience by their response to sur-
veys about various aspects of their health. The responses
are converted into a single score through specific scoring
algorithms [5]. In this study, we used indirect methods
to estimate the health preference by SF-6D through
regression-based mapping [6].
Studies showed that DM highly impaired HRQoL
[7–10]. However, few studies have differentiated the
impacts due to DM alone and those from DM-related
complications. It is reported that different diabetic
complications may jeopardize different domains of
HRQoL. Macrovascular complications (heart disease
and stroke) were found to affect only physical do-
mains of HRQoL in some studies [11–13], but often
observed an impact on both physical and mental do-
mains [14, 15]. In terms of microvascular complica-
tions (nephropathy, retinopathy and neuropathy), only
the severe level of disease consistently showed lower
scores in physical aspect of HRQOL [11–13]. How-
ever, most of these studies rely on self-reported dis-
eases, therefore only complications with severe
clinical manifestations were frequently studied. Few
studies have examined the whole spectrum of compli-
cations, especially in asymptomatic patients using
standardized clinical diagnosis. Cong et al. estimated
the HRQoL among Chinese patients with T2DM in
Tianjin by the diabetes-specific HRQoL questionnaire
found that diabetic neuropathy, peripheral vascular
disease (PVD) and coronary heart disease (CHD) were
associated with decreased HRQoL. However, this
study was conducted in a limited number of subjects
(N = 174) that they did not study the impact of the
whole spectrum of complications on HRQoL. Also,
the disease-specific HRQoL questionnaire only pro-
vides one single score to measure the HRQoL that it
could not tell the impact of complications on differ-
ent HRQoL domains [16].
Many overseas studies have reported the impact of dif-
ferent DM-related complications on health preference
[17–19]. Renal failure, heart failure and amputation were
reported as the complications associated with most re-
duction in health preference [20]. Health preference
seems sensitive to patients’ cultural and socioeconomic
characteristics. Besides the discrepancies in age, sex, dis-
ease severity and case definitions, culture and population
setting can greatly influence HRQOL utility perceptions
[17]. Despite lying on the same metric of health prefer-
ence measure, variations in health preference values
were found in association with DM and its complica-
tions in different studies [21, 22], prompting that health
preference is population specific. A study showed that
the EQ-5D health preference for the same disease states
were valuated differently between the UK subjects and
the US subjects [23]. Among the 42 health states mea-
sured by SF-6D, the US mean valuations were higher
than the UK for 39 health states with a mean difference
of 0.11 (range: -0.01 to 0.25) [23]. Therefore, to accur-
ately evaluate the effectiveness and cost-effectiveness of
DM interventions in our Chinese population, local em-
pirical data on HRQoL and health preference associated
with DM and its complications are required. Luk et al.
estimated the health preference of Chinese T2DM in
Hong Kong by EQ- 5D using the UK tariff. Three dia-
betic complications were found to be associated with
significant decrease in EQ-5D index, including nephrop-
athy, neuropathy and cardiovascular disease, with decre-
ments of 0.014, 0.063 and 0.034, respectively. This study
did not differentiate the severity of microvascular com-
plications and was based on the UK tariff [24]. A recent
study reported the associations between self-reported
diabetic complications and health preference measured
by EQ-5D-5L. Heart disease and cerebrovascular disease
were found to have decrements of 0.074 and 0.16. This
study did not cover the whole spectrum of diabetic com-
plications, such as nephropathy and the complications
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were self-reported [25]. Previous economic evaluation
studies on DM management in Chinese population were
limited by the lack of health preference data in Chinese
diabetic patients [26–28].
To date, little is known about, to what extent, whether
DM and various DM-related complications affect
HRQoL and health preference in a Chinese population.
The prevalence of DM has accelerated in Asia, and
China is now among the countries with the highest dia-
betes prevalence in Asia with a prevalence of 11.6%
among adult population [29]. Several unique factors in
Asians, especially in Chinese, might contribute to the
rapid increase in DM epidemic, including the “normal-
weight metabolically obese” phenotype; high intake of
refined carbohydrates (e.g., white rice); dramatically de-
creased physical activity levels; and poor nutrition in
utero and in early life combined with overnutrition in
later life [30]. This study aimed to evaluate HRQoL and
health preference of DM patients without complications
and those with major DM-related complications includ-
ing heart diseases, stroke, chronic kidney disease and
retinopathy, thus to provide the contemporary empirical
data for economic evaluation of DM management in
Chinese population.
Methods
A cross-sectional study was conducted to measure the
HRQoL and health preference for uncomplicated and
complicated DM.
Subjects
The study subjects included two convenience samples,
one from primary care setting and another one from
secondary care. The former composed of diabetic pa-
tients recruited from Hospital Authority primary care
general outpatient clinics (GOPC) in all seven clusters in
Hong Kong. From September 2012 to January 2013, pa-
tients with DM were recruited for evaluation of Patient-
reported outcome as part of evaluation of two quality
improvement programs namely, multidisciplinary Risk
Assessment and Management Program for patients with
Diabetes Mellitus (RAMP-DM) [31, 32] and Patient Em-
powerment Programme [33, 34]. We adopted the base-
line data of these subjects to avoid the effects of the
interventions. The inclusion criteria were 1) aged 18 or
above; and 2) with documented diagnosis of DM (ICPC-
2 code T89/T90: insulin dependent DM/ non-insulin
dependent DM) in the clinical management system.
To complement the GOPC sample in whom most (77%)
of them were free from complications, the latter one was
sampled from diabetic patients with known complications
attending secondary care hospital-based setting endocrin-
ology and nephrology specialist clinics in the Queen Mary
Hospital and ophthalmology specialist clinic in Grantham
Hospital. The inclusion criteria were 1) aged 18 or above;
2) with documented diagnosis of DM (ICD-9- CM code
250: diabetes mellitus) in HA clinical management system
(CMS); 3) Documented diagnosis of at least one of the fol-
lowing DM-related complications: a) heart disease (coron-
ary heart disease and/ or heart failure), b) stroke, c)
nephropathy, or d) diabetic retinopathy with or without
blindness. Exclusion criteria for both samples were 1) in-
ability to complete an interview due to cognitive impair-
ment base on the judgement of the attending clinician; 2)
too ill to carry out an interview; 3) patients with other ser-
ious conditions, including cancer, chronic lung disease
and dementia.
Written consents were obtained from all recruited
subjects. Each recruited subject was contacted through
telephone within 1 month after recruitment dates by
trained interviewers of the Social Science Research
Center of The University of Hong Kong to complete the
Chinese (HK) SF-12v2 Health Survey and a question-
naire on socio-demographics and private health services
utilization.
As shown in Fig. 1, 1825 and 375 diabetic patients
were recruited from primary care and hospital-based
secondary care setting, respectively. Out of these, 1499
(82.1%) and 290 (77.3%) subjects completed the tele-
phone interview, respectively. Among the subjects re-
cruited from primary care, 514 subjects were excluded
because of failure to be linked to the HA CMS to ascer-
tain whether they had complications or not. The per-
sonal information of these 514 subjects were not well
collected at the recruiting period. Therefore, we could
not identify their clinical information in the Hospital
Authority Clinical Management System. A total of 1275
subjects were included in the data analysis. Among these
study subjects, 518 (40.6%) subjects were clinically diag-
nosed with at least one DM-related complication.
Ethics approval of the study has been sought by HKU/
HA Institutional Review Board.
Characteristics of study subjects
Socio-demographic characteristics including marital status
and individual monthly income was self-reported by sub-
jects during telephone interview. Clinical characteristics
including age, sex, smoking status, duration of DM,
HbA1c, blood pressure, lipid profiles and clinical diagno-
ses of diabetic complications were extracted from the
Clinical Management System of the Hospital Authority in
Hong Kong. The ICPC-2 and ICD-9-CM codes of diabetic
complications are listed in Additional file 1: Table S1.
Evaluation of Health-related Quality of Life and Health
preference
The Chinese (Hong Kong) Short Form-12v2 (SF-12v2)
was used to measure HRQoL. The SF-12v2 is a widely
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used generic HRQoL. The Chinese version has been vali-
dated and normed in the general Chinese population in
Hong Kong [35], and measured HRQOL in local patients
with DM [36, 37]. Eight domains of HRQoL are mea-
sured on a scale range from 0 to 100, including physical
functioning (PF), role physical (RP), bodily pain (BP),
general health (GH), vitality (VT), social functioning
(SF), role emotional (RE) and mental health (MH). A
higher score indicates better HRQoL. The eight domain
scores are aggregated based on standardized weights and
norm-based on the mean and SD of the Hong Kong
population weights to calculate two summary scores, the
physical (PCS) and mental component summary (MCS)
scores [38].
Health preference was measured by the SF-6D that is
derived from seven of twelve items of the SF-12v2 [39]
calculated by the Hong Kong Chinese population-
specific scoring algorithm [40, 41]. The theoretical range
of SF-6D preference- based utility score ranges from 1
for full health to 0.315 for the worst possible health state
for the Chinese Hong Kong population [40, 41].
Statistical analysis
The SF-12v2 and SF-6D preference-based utility scores
were calculated for each study subjects by the Hong
Kong population specific algorithm [41]. Independent t-
test and Tukey’s post hoc test were employed as appro-
priate to detect any difference in SF-12v2 and SF-6D
scores for between groups and multiple groups compari-
son, respectively. Multivariable linear regressions were
performed to estimate the independent effects associated
with each subtype of DM- related complications on SF-
12v2 and SF-6D scores, adjusting for the socio-
demographic factors and clinical parameters. The
Fig. 1 Flowchart of patient recruitment and interview. *Some subjects had more than one complications. CKD, chronic kidney disease; ESRD, end-
stage renal disease; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; STDR, sight-threatening diabetic retinopathy
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regression was modeled using ordinary least squares
(OLS) regression with robust standard errors. Although
different methods were employed to regress the data due
to the skewed distribution of HRQoL data [19, 42, 43],
OLS regression is the commonest used method. More-
over, a study comparing OLS with other methods finds
that OLS is a valid approach [44].
To determine whether there were differences in the
HRQoL and health preference between diabetic patients
and healthy population, we selected an age-sex stratified
sample from our study subjects and an age-sex matched
control sample randomly selected from a representative
sample of 2533 Hong Kong general Chinese population,
who had completed the SF-12v2 health survey in 2010
in a primary care service utilization study [38]. Among
the 2533 general population, 888 subjects had self-
reported chronic diseases, and they were excluded from
matching. We did not perform a one-to-one matching
because our study subjects were much older than the
general population sample dataset, making a match pair
for all the study subjects impossible. We were able to
obtain a matched sub-sample of 220 pairs of our study
subjects and the general population samples.
To determine the impact of number of complications
on HRQoL and health preference, we divided subjects
into three groups by the number of complications,
which were subjects with no complication, with only
one complication and with two or more complications.
Tukey’s Post-hoc multiple comparisons were employed
to compare the three groups.
All data analyses were performed using STATA
Version 13.0 (StataCorp LP. College Station, Texus, US),
and P- value less than 0.05 was considered statistically
significant.
Results
Basic characteristics of study subjects
Table 1 shows the characteristics of the study subjects
by disease status. The average age of study subjects with-
out complications were generally younger than that of
those with complications. The average duration of pa-
tients with uncomplicated DM was 7.76 years, which
was shorter than those of subjects with any complica-
tion, whose duration of DM ranged from 10 to 17 years.
Compared to subjects without any diabetic complica-
tions, subjects with complications all had lower TC and
LDL-C, which might be due to intensive lipid-lowering
treatments.
The age and sex between subjects included in the ana-
lysis and those excluded from the analysis were com-
pared. Compared to subjects included in the analysis,
the subjects excluded from the analysis were younger
(63.87 ± 11.33 vs 64.84 ± 10.26, P = 0.037). The sex
distribution was similar between these two groups (Add-
itional file 1: Table S2).
Comparison between Study Subjects and the General
Healthy Population Sample
Table 2 presents the SF-12v2 and SF-6D health prefer-
ence scores of diabetic patients and age-sex matched the
general healthy population sample. The age-sex stratified
subset of study subjects had similar SF-12v2 and SF-6D
health preference scores as those of all study subjects.
Compared to the general healthy population sample,
study subjects had lower scores in SF-12v2 PF, BP, GH,
VT, and PCS scores. The health preference score was
similar between our study diabetic patients and the gen-
eral healthy population sample (0.862 ± 0.113 versus
0.863 ± 0.102, P = 0.922).
SF-12v2 Scores
The SF-12v2 scores of study subjects are shown in Table
3. Compared to the general healthy population sample,
both uncomplicated and complicated diabetic patients
had lower PCS. Uncomplicated diabetic patients had
higher scores in SF, RE, MH and MCS, but lower scores
in GH, VT and PCS. Complicated diabetic patients all
showed lower scores in PF, BP, GH and VT than the
general healthy population sample.
Compared to uncomplicated diabetic patients, compli-
cated diabetic patients except those with NPDR/pre-PDR,
all had lower scores in PCS. Subjects with cardiovascular
complications had lower scores in all the SF-12v2 domain
scores except MH score for heart disease and GH for
stroke. In terms of microvascular disease, subjects with
NPDR or pre-PDR and moderate reduced renal function
did not show much difference in SF-12v2 scores com-
pared to subjects without complications, while subjects
with STDR and ESRD showed lower means in most SF-
12v2 scores.
After adjustment for socio-demographic, clinic param-
eters and co-existing complications, subjects with any
diabetic complications had lower in all SF-12v2 domain
scores except MH and MCS, compared to those without
complications (Table 4). Stroke, ESRD, STDR were asso-
ciated with lower scores in most SF-12v2 domains, while
NPDR/pre-PDR was not associated with any significant
decrease or increase in any SF-12v2 scores. Heart disease
was associated with lower scores in GH and SF.
SF-6D Health Preference Scores
Table 5 shows the SF-6D health preference scores. Com-
pared to the general healthy population sample, the un-
complicated diabetic patients had higher health
preference score (0.882 ± 0.102 versus 0.863 ± 0.102,
P = 0.025). Subjects with heart diseases, stroke, ESRD
and STDR had lower SF-6D health preference scores
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than the general healthy population sample and uncom-
plicated diabetic patients.
After adjustment for socio-demographic and clinical
parameters, stroke, ESRD and STDR were associated
with lower SF-6D health preference, with reductions of
−0.042 (95% CI -0.072 to −0.012), −0.055 (95% CI -0.093
to −0.017) and −0.043 (95%CI -0.075 to −0.010), respect-
ively. The marginal effect of heart disease became insig-
nificant (−0.017, 95% CI -0.042 to 0.008).
SF-12v2 and SF-6D Health Preference Scores by numbers
of complications
Table 6 presents the associations between number of
diabetic complications and SF-12v2 and SF-6D health
preference scores. The impact on HRQoL increased
with the development of complications especially if
there were two or more. Subjects with only one
complication showed lower scores in PF, RP, BP, SF,
RE and PCS, as well as health preference than sub-
jects without complications. Subjects with two or
more complications had lower SF-12v2 PF, RP, BP,
VT, PCS and SF-6D health preference scores than
those with only one complication.
Discussion
To the best of our knowledge, this was the first study to
investigate the different effects of specific diabetic com-
plications on HRQoL and health preference in a Chinese
population. Patients with history of any of the four
major DM-related complications (heart disease, stroke,
ESRD and STDR) had lower SF-12v2 and SF-6D health
preference scores than the general healthy population
sample, as well as uncomplicated DM. After adjusted for
socio-demographic and clinical parameters, heart disease
was associated with lower GH and SF, but not SF-6D
Table 1 Characteristics of study subjects
Variables All study
subjects
Without diabetic
complication
Heart Diseases Stroke Diabetic
nephropathy
ESRD NPDR/
pre-PDR
STDR
(N = 1275) (N = 757) (N = 113) (N = 72) (N = 233) (N = 75) (N = 114) (N = 66)
Age (years) 64.84 ± 10.26 63.38 ± 9.52 68.28 ± 8.54 70.22 ± 10.37 69.80 ± 10.09 65.17 ± 10.94 63.22 ± 10.52 63.96 ± 10.72
Male 46.75% 41.16% 63.72% 58.33% 46.78% 66.67% 60.53% 66.67%
Current smoker 19.85% 22.32% 16.35% 25.81% 13.84% 9.09% 10.19% 12.00%
Duration of
DM (years)
9.35 ± 7.49 7.76 ± 6.27 14.26 ± 9.78 10.12 ± 8.25 11.08 ± 8.58 14.31 ± 16.89 17.08 ± 9.41 14.52 ± 9.61
SBP (mmHg) 138.30 ± 17.01 138.85 ± 16.83 133.73 ± 16.00 136.62 ± 16.27 137.79 ± 17.97 135.46 ± 16.89 136.02 ± 18.40 135.38 ± 19.15
DBP(mmHg) 76.38 ± 11.11 77.94 ± 10.18 71.87 ± 12.41 74.11 ± 10.85 73.92 ± 12.02 66.44 ± 11.13 73.00 ± 12.13 67.66 ± 12.01
HbA1c (%) 7.37 ± 1.25 7.38 ± 1.21 7.49 ± 1.32 7.10 ± 1.18 7.24 ± 1.06 7.06 ± 1.18 7.95 ± 1.30 6.92 ± 1.31
TC (mmol/L) 4.76 ± 1.36 4.91 ± 0.91 3.95 ± 0.91 4.51 ± 0.91 4.57 ± 1.05 4.32 ± 1.21 4.60 ± 3.27 4.31 ± 1.37
HDL-C (mmol/L) 1.30 ± 0.37 1.35 ± 0.36 1.09 ± 0.32 1.35 ± 0.42 1.24 ± 0.35 1.16 ± 0.37 1.17 ± 0.40 1.15 ± 0.40
LDL-C (mmol/L) 2.74 ± 0.86 2.87 ± 0.81 2.12 ± 0.78 2.56 ± 0.77 2.62 ± 0.92 2.40 ± 0.89 2.36 ± 0.94 2.34 ± 0.95
Triglyceride
(mmol/L)
1.56 ± 1.03 1.53 ± 0.91 1.69 ± 1.21 1.36 ± 1.16 1.65 ± 0.98 1.88 ± 1.85 1.67 ± 1.19 1.91 ± 2.29
Marital status
Single 6.27% 5.01% 6.19% 5.56% 6.87% 8.00% 12.28% 7.84%
Married 73.65% 75.99% 71.68% 65.28% 67.38% 78.67% 74.56% 82.35%
Divorce/
Separated
5.18% 5.28% 4.42% 8.33% 5.58% 4.00% 4.39% 3.92%
Widow/
Widower
14.90% 13.72% 17.70% 20.83% 20.17% 9.33% 8.77% 5.88%
Individual monthly income (HKD)
< 2000 59.14% 60.16% 43.36% 62.50% 65.24% 68.00% 35.96% 72.55%
2000–14,999 31.45% 32.45% 40.71% 30.56% 25.32% 22.67% 42.11% 17.65%
15,000–29,999 6.75% 5.28% 14.16% 4.17% 6.44% 5.33% 13.16% 5.88%
> 29,999 2.67% 2.11% 1.77% 2.78% 3.00% 4.00% 8.77% 3.92%
Figures are expressed as Mean ± SD or % as appropriate
DBP diastolic blood pressure, DM diabetes mellitus, HbA1c glycated hemoglobin A1c, HDL-C high density lipid cholesterol, LDL-C low density lipid cholesterol, SBP
systolic blood pressure, TC total cholesterol. ESRD end-stage renal disease, NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy, STDR
sight-threatening diabetic retinopathy
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health preference. Stroke, ESRD and STDR were associ-
ated with lower PF, RP, BP, SF and PCS and SF-6D health
preference. None of the complications were associated
with lower MH and MCS.
Compared to the general healthy population sample,
uncomplicated DM had lower scores in GH, VT and
PCS, but higher scores in SF, RE, MH and MCS. As a
result, the SF-6D health preference in uncomplicated
DM was higher than that of the general healthy popula-
tion sample. A few previous studies had compared the
HRQoL of diabetic patients with non-diabetic patients.
The findings on the impact of DM on HRQoL and
health preference were inconclusive. A study in
Singapore population showed that the HRQoL
Table 2 Comparison of health-related quality of life and SF-6D health preference between study subjects and age-sex matched gen-
eral healthy population
Scales All study
subjects
Comparison
Sampled study subjectsa General healthy population P value
(N = 1275) (N = 220) (N = 220)
Health related quality of life
PF 80.46 ± 29.67 80.34 ± 28.72 86.82 ± 24.65 0.012
RP 80.65 ± 27.97 80.00 ± 26.40 84.32 ± 23.19 0.069
BP 79.00 ± 27.76 77.61 ± 28.40 82.73 ± 24.65 0.044
GH 36.56 ± 24.44 36.68 ± 24.26 51.77 ± 28.94 <0.001
VT 58.86 ± 29.96 56.93 ± 31.34 65.80 ± 26.67 0.002
SF 86.80 ± 26.26 82.61 ± 30.25 85.45 ± 23.62 0.273
RE 86.31 ± 22.97 83.13 ± 25.11 83.07 ± 20.94 0.979
MH 78.10 ± 21.20 76.76 ± 22.64 74.20 ± 20.22 0.212
PCS 45.89 ± 10.94 46.05 ± 10.41 50.33 ± 9.81 <0.001
MCS 54.97 ± 10.47 53.44 ± 11.78 52.75 ± 10.01 0.508
Health preference
SF-6D score 0.868 ± 0.113 0.862 ± 0.113 0.863 ± 0.102 0.922
Figures are expressed as Mean ± SD
BP bodily pain, GH general health, MCS mental component summary score, MH mental health, PCS physical component summary score, PF physical functioning,
RE role emotional, RP role physical, SF social functioning, VT vitality
aProportional sampling from the total study subjects, all the items were not significantly different from total study subjects
Table 3 Health-related quality of life of Chinese patients with diabetes mellitus with and without complication in comparison with
general healthy population
HRQoL General Healthy
population
Without diabetic
complication
Heart
Diseases
Stroke Diabetic
Nephropathy
ESRD NPDR /
pre-PDR
STDR
(N = 220) (N = 757) (N = 113) (N = 72) (N = 233) (N = 75) (N = 114) (N = 66)
PF 86.82 ± 24.65 85.63 ± 25.83 70.54 ± 33.76* 73.26 ± 37.13* 70.92 ± 33.79* 64.53 ± 32.32* 80.31 ± 27.64 68.56 ± 33.77*
RP 84.32 ± 23.19 84.33 ± 25.56 73.78 ± 31.16* 69.79 ± 37.10* 76.66 ± 29.69* 70.00 ± 30.55* 78.95 ± 28.33 71.40 ± 31.15*
BP 82.73 ± 24.65 82.39 ± 25.18 71.46 ± 29.86* 68.40 ± 36.82* 77.36 ± 27.26* 69.00 ± 32.84* 76.75 ± 27.97* 67.80 ± 34.18*
GH 51.77 ± 28.94 37.59 ± 23.91 32.61 ± 24.74* 33.68 ± 23.87 35.00 ± 24.89 35.07 ± 25.29 39.12 ± 26.63 29.09 ± 23.32*
VT 65.80 ± 26.67 61.68 ± 28.19 49.56 ± 33.24* 50.00 ± 34.85* 59.44 ± 29.21 45.67 ± 30.31* 54.61 ± 33.02* 50.38 ± 32.07*
SF 85.45 ± 23.62 89.81 ± 22.72 77.88 ± 35.16* 78.82 ± 35.27* 86.27 ± 25.83 74.33 ± 34.38* 84.43 ± 28.88* 76.52 ± 35.05*
RE 83.07 ± 20.94 88.42 ± 20.43 80.20 ± 26.76* 79.17 ± 30.90* 86.86 ± 21.89 77.00 ± 29.64* 84.10 ± 26.52* 79.55 ± 28.81*
MH 74.20 ± 20.22 78.78 ± 19.70 75.88 ± 24.25 72.05 ± 26.66* 78.54 ± 22.19 75.67 ± 22.78 77.63 ± 23.19 74.43 ± 23.15
PCS 50.33 ± 9.81 47.71 ± 9.75 42.36 ± 12.20* 42.55 ± 14.27* 43.05 ± 12.08* 40.81 ± 11.52* 45.75 ± 10.28 41.12 ± 12.24*
MCS 52.75 ± 10.01 55.30 ± 9.53 52.96 ± 12.55* 52.05 ± 13.49* 56.45 ± 10.73 52.36 ± 12.43* 53.89 ± 11.64 52.94 ± 11.39
Figures in bold-P < 0.05 compare to general healthy population
Figures expressed as Mean ± SD
BP bodily pain, ESRD end-stage renal disease, GH general health, MCS mental component summary score, MH mental health, PCS physical component summary
score, PF physical functioning, RE, role emotional, RP role physical, SF social functioning, VT vitality, NPDR non-proliferative diabetic retinopathy, PDR proliferative
diabetic retinopathy, STDR sight-threatening diabetic retinopathy
*P < 0.05 compared to subjects without complications
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(measured by the SF-36 health survey) and SF-6D health
preference score in diabetic patients without vascular
complications were not significantly different from that of
non-diabetic subjects [11]. A study in Spain also showed
that health preference measured by the EQ-5D was not
significantly lower in diabetic subjects without vascular
complications compared to non-diabetic subjects [45].
Studies that did not adjust for diabetic complications
found that diabetic patients had worse HRQoL than
non-diabetic patients [7, 46–48]. There were several
explanations for the discrepancy between our findings
and previous studies. First, the lower HRQoL in pre-
vious studies might be due to the presence of DM-
related complications in some study subjects. Second,
all the previous studies used self-reported diagnosis of
DM, while our study defined DM and complications
by documented diagnosis in medical records by chart
review. Third, subjects with DM tend to seek differ-
ent ways of physical and emotional rehabilitation in
person or in group. Their active response to their
situation probably has a role in their better quality of
life. Literature showed that both individual and
Table 4 Decrement in health-related quality of life associated with the presence of diabetic complication and individual
complication
HRQoL Any diabetic
complicationa
Individual complicationsb
Heart disease Stroke Diabetic nephropathy ESRD NPDR/pre-PDR STDR
PF -10.61 ± 1.83* −4.04 ± 3.15 −5.81 ± 3.75 −7.76 ± 2.19 −18.78 ± 4.83* −0.04 ± 3.41 −14.41 ± 4.08*
RP -7.19 ± 1.81* −0.84 ± 3.14 −9.08 ± 3.74* −3.48 ± 2.18 −12.06 ± 4.78* −1.51 ± 3.39 −8.46 ± 4.07*
BP -7.25 ± 1.81* −3.00 ± 3.13 −11.02 ± 3.73* −1.54 ± 2.18 −14.16 ± 4.77* 1.14 ± 3.38 −11.18 ± 4.06*
GH -3.63 ± 1.63* −5.02 ± 2.81¶ −2.77 ± 3.35 −2.38 ± 1.95 −8.39 ± 4.28* 5.03 ± 3.03 −4.41 ± 3.64
VT -6.82 ± 1.97* −4.99 ± 3.40 −4.92 ± 4.06 −1.46 ± 2.37 −17.88 ± 5.19* −2.49 ± 3.67 −7.42 ± 4.41
SF -5.96 ± 1.73* −5.95 ± 2.97* −7.29 ± 3.55* −1.11 ± 2.07 −13.58 ± 4.54* 2.66 ± 3.21 −8.74 ± 3.86*
RE -4.81 ± 1.48* −2.91 ± 2.55 −6.67 ± 3.05* −0.64 ± 1.78 −9.67 ± 3.90* 0.40 ± 2.76 −3.49 ± 3.31
MH -1.44 ± 1.40 −1.04 ± 2.42 −4.32 ± 2.88 −0.26 ± 1.68 −2.90 ± 3.69 2.52 ± 2.61 −5.01 ± 3.13
PCS -3.81 ± 0.69* −1.40 ± 1.19 −3.05 ± 1.42* −2.32 ± 0.83* −7.05 ± 1.83* −0.07 ± 1.29 −4.93 ± 1.55*
MCS -0.86 ± 0.68 −1.44 ± 1.18 −2.15 ± 1.41 0.63 ± 0.82 −13.58 ± 1.81* 0.65 ± 1.28 −1.13 ± 1.53
Figures expressed as Mean ± SE
BP bodily pain, ESRD end-stage renal disease, GH general health, MCS mental component summary score, MH mental health, PCS physical component summary
score, PF physical functioning, RE role emotional, RP role physical, SE standard error, SF social functioning, VT vitality. NPDR non-proliferative diabetic retinopathy,
PDR proliferative diabetic retinopathy, STDR sight-threatening diabetic retinopathy
aAdjusted for age, sex, smoking status, duration of DM, SBP, DBP, HbA1c, TC, HDL-C, LDL-C, triglyceride, marital status and individual monthly income
bAdjusted for age, sex, smoking status, duration of DM, SBP, DBP, HbA1c, TC, HDL-C, LDL-C, triglyceride, marital status and individual monthly income and
other complications
*P < 0.05, ¶ P = 0.074
Table 5 Decrement in SF-6D health preference score associated with the presence of diabetic complication and individual
complication
SF-6D health
preference scores
Compare to general
population sample
Compare to subjects
without complications
Decrements of specific complicationsa
Mean ± SD P value P value Estimated
coefficients
95% CI P value
General healthy population (N = 220) 0.863 ± 0.102 NA NA
Without diabetic complication (N = 757) 0.882 ± 0.102 0.025 NA
Individual complications
Heart Diseases (N = 113) 0.834 ± 0.131 0.029 <0.001 −0.017 (−0.042,0.008) 0.190
Stroke (N = 72) 0.822 ± 0.150 0.01 <0.001 −0.042 (−0.072,-0.012) 0.005
Nephropathy (N = 233) 0.858 ± 0.117 0.029 <0.001 −0.011 (−0.029,0.006) 0.194
ESRD (N = 75) 0.820 ± 0.122 0.003 <0.001 −0.055 (−0.093,-0.017) 0.004
NPDR/pre-PDR (N = 114) 0.865 ± 0.124 0.881 0.139 0.004 (−0.024,0.032) 0.769
STDR (N = 66) 0.828 ± 0.130 0.023 <0.001 −0.043 (−0.075,-0.010) 0.010
Intercept: 0.883, 95% CI (0.778,0.989)
ESRD end-stage renal disease, NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy, STDR sight-threatening diabetic retinopathy
aAdjusted for age, sex, smoking status, duration of DM, SBP, DBP, HbA1c, TC, HDL-C, LDL-C, triglyceride, marital status and individual monthly income and
other complications
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group-based rehabilitation can improve DM patients
HRQoL [49]. Forth, compared to our study subjects,
subjects in these studies had lower proportion of be-
ing married [7, 46–48]. Our study showed that di-
vorce/separated (coefficient − 0.041, P = 0.031, data
not shown) and widowed (coefficient − 0.044,
P = 0.009, data not shown) was negatively associated
with health preference with married as reference
group.
Although subjects with heart disease might not feel ob-
vious body pain or role limitation, and there was minimal
impairment of their physical functioning and role func-
tioning (Tables 5 and 6), they still reported worse general
health (decrement: -5.02, P = 0.062) and social functioning
(decrement: -5.95, P < 0.05) probably because they were
conscious and being cautious of life-threatening disease.
Mild, reversible disease (nephropathy and NPDR/pre-
PDR) did not lead to significant decrease in any SF-12v2
domains because they are asymptomatic. However, when
the disease progressed to severer stage and became irre-
versible (ESRD and STDR), almost all the SF-12v2 do-
mains had significant lower scores except MH. Therefore,
it is important to screen and treat early these complica-
tions in DM subjects to preserve HRQoL.
None of the four major diabetic complications (heart
disease, stroke, ESRD and STDR) were associated with
lower mental aspect of HRQOL, which was consistent
with overseas studies using SF-36 or SF-8 [11, 12, 50]. In
our study, heart disease was found to have lower PCS
than the general healthy population sample and subjects
without complications, but the decrease was no longer
significant after adjusting for clinical covariates and co-
existing complications. Previous studies found that is-
chemic heart disease was associated with lower PCS in
Singapore population [11, 13], the US [12] and UK [50].
Only one study in Singapore population (including 60%
Chinese subjects) reported the impact of diabetic com-
plications on 8 domains of HRQoL [11]. They found se-
vere retinopathy was associated with lower scores in PF
and RP, which was consistent to our study. Stroke was
only associated with lower PF in Singapore population,
while we found that patients with stroke had lower
scores in RP, BP, SF, RE and PCS. There were only 10
subjects with stroke in the Singapore study, which could
lead to wide variation in the scores.
Most previous studies on the health preference scores of
diabetic patients employed EQ-5D [20, 51, 25, 52], one
study in Singapore population (60% of the study subjects
were Chinese) used SF-6D [11]. The SF-6D scores were
0.79 for non-diabetic subjects and 0.78 for uncomplicated
DM in Singapore population [11], and the difference was
not significant. The SF-6D score were lower than those
found in our Hong Kong Chinese population, which were
0.86 for the general healthy population sample without
DM and 0.88 for uncomplicated DM. Compared to un-
complicated DM, decrements of 0.02 to 0.03 in the SF-6D
Table 6 Decrement in health-related quality of life and health preference associated with the number of diabetic complications
Scales Number of complications Effects of number of complicationsb
0 (N = 757) 1 (N = 379) ≥2 N = 139) Multiple comparisona 1 (N = 379) 2 (N = 119) ≥3 (N = 18)
(1)
Mean ± SD
(2)
Mean ± SD
(3)
Mean ± SD
Compare (1), (2) &(3) Mean ± SE Mean ± SE Mean ± SE
Health related quality of life
PF 85.6 ± 25.8 75.6 ± 33.0 67.0 ± 32.7 (1) > (2); (1),(2) > (3) −9.26 ± 1.97* −12.51 ± 3.18* −20.04 ± 7.51*
RP 84.3 ± 25.6 77.4 ± 29.4 71.0 ± 32.2 (1) > (2); (1),(2) > (3) −5.78 ± 1.95* −8.49 ± 3.16* −8.51 ± 7.24
BP 82.4 ± 25.2 76.5 ± 29.8 69.1 ± 31.1 (1) > (2); (1),(2) > (3) −5.43 ± 1.96* −10.20 ± 3.16* −6.26 ± 7.25
GH 37.6 ± 23.9 36.4 ± 25.4 31.9 ± 24.2 (1) > (3) −2.75 ± 1.75 −6.00 ± 2.83* −3.54 ± 6.49
VT 61.7 ± 28.2 57.3 ± 31.8 49.6 ± 31.7 (1) > (3); (1),(2) > (3) −5.05 ± 2.12* −7.53 ± 3.43* −23.69 ± 7.88*
SF 89.8 ± 22.7 84.0 ± 28.9 79.0 ± 33.1 (1) > (2); (1) > (3) −5.04 ± 1.86* −6.85 ± 3.01* −11.84 ± 6.90
RE 88.4 ± 20.4 84.5 ± 25.5 80.7 ± 26.8 (1) > (2); (1) > (3) −4.52 ± 1.59* −3.88 ± 2.57 −6.26 ± 5.90
MH 78.8 ± 19.7 78.4 ± 22.5 74.2 ± 24.4 −0.75 ± 1.51 −2.42 ± 2.43 −5.10 ± 5.58
PCS 47.7 ± 9.7 44.3 ± 11.7 41.1 ± 12.2 (1) > (2); (1),(2) > (3) −3.11 ± 0.74* −4.91 ± 1.20* −5.55 ± 2.84*
MCS 55.3 ± 9.5 55.0 ± 11.3 53.4 ± 12.5 −0.63 ± 0.74 −0.66 ± 1.19 −4.07 ± 2.81
Health preference
SF-6D score 0.882 ± 0.102 0.859 ± 0.120 0.827 ± 0.132 (1) > (2); (1),(2) > (3) −0.022 ± 0.008* −0.036 ± 0.013* −0.065 ± 0.029*
PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health, PCS Physical
Component Summary score, MCS Mental Component Summary score
a Significant difference between three groups by Tukey’s Post-hoc multiple comparisons
b Adjusted for age, sex, smoking status, duration of DM, SBP, DBP, HbA1c, TC, HDL-C, LDL-C, triglyceride, marital status and individual monthly income and
other complications
* P < 0.05
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scores were observed for diabetic patients with coronary
heart disease, stroke, severe retinopathy and severe ne-
phropathy respectively in the Singapore study. Another
study in Australian overweight or obese subjects used the
SF-6D and found that DM was not associated lower SF-
6D preference score but CHD decreased health preference
by 0.054 [53]. In the Chinese population in our study, the
decrements in health preference were 0.031, 0.051, 0.047
and 0.037 for subjects with heart disease, stroke, ESRD
and STDR. The SF-6D scores in our study were calculated
by the Hong Kong Chinese population-specific scoring al-
gorithm [40, 41], while the Singapore study and Australia
study adopted the algorithm derived from UK general
population [54]. In regarding to sociodemographic param-
eters, the subjects in the Singapore study was younger
than our subjects (48 ± 11 vs 65 ± 10 years-old), lower
proportion of subjects were separated/divorced/widowed
(5.7% vs 20.8%). Only 60% subjects were Chinese and 40%
were Malay and India in the Singapore study. Our study
showed that age was not significantly associated with
changes in health preference while divorce/separated and
widowed was negatively associated with health preference
with married as reference group. The lower health prefer-
ence in the Singapore study was not likely to be explained
by the differences in sociodemographic characteristics.
The differences in scoring algorithm and population
composition might cause the differences in the health
preference.
This study found that subjects with two or more com-
plications showed significantly lower scores than those
with only one complication in physical component
scores and SF-6D score, but unexpectedly MH and MCS
scores were not significantly decreased with the increase
in the number of complications. A study in Norway
population using EQ-5D also showed a marked differ-
ence in health preference scores for DM patients with
only one complication (0.80) and subjects with two or
more complications (0.64) [18].
There were several strengths in this study. First, the
numbers of subjects with and without diabetic complica-
tions were large enough to detect the relative differences
in HRQoL and health preference. Second, purposeful
sampling enabled us to assess the impact of different
complications on HRQoL and health preference. Third,
disease status was defined by documented clinical diag-
noses, which are more reliable than self-reported dis-
eases. Fourth, comprehensive demographic and clinical
parameters were included in the regressions to deter-
mine the independent associations between specific dia-
betic complications and health preference.
The limitations of our study should be considered
when interpreting the study results. First, we did not dif-
ferentiate T1DM and T2DM in this study because
T2DM accounted for over 90% of all diabetic patients
[2], although this is not likely to affect our conclusions.
Second, it was a cross-sectional study in which only as-
sociation but not causation could be established. Third,
we used telephone survey to collect HRQoL which
might select respondents with better HRQoL and biased
towards higher HRQoL scores. The same bias should
have been applied to all the subjects, so the relative dif-
ferences among different disease states were less likely
to be biased. Fourth, the drop-out rate in the GOPC
sample was relatively high (46.0%) due to incomplete in-
formation collection during the recruit period for 514
subjects, although all of them completed the telephone
interview. The high drop-out rate caused a reduction in
the sample size. Since all of these 514 subjects were ran-
domly lost due to accidental cause instead of refusal, this
was not likely to cause selection bias. Fifth, education
level is an important sociodemographic factor, but we
did not include it into analysis due to high missing rate
(25%). Living place area was an important sociodemo-
graphic factor to reflect the socioeconomic status, of
which was not collected in telephone survey.
Conclusions
The HRQoL and health preference of Chinese diabetic
patients without complications were not worse than
those of the general healthy population. The presence of
any of the four major diabetic complications (heart dis-
ease, stroke, ESRD and STDR) was associated with sig-
nificantly lower HRQoL and health preference scores.
To preserve HRQOL in the long-term, preventing or
delaying the onset of diabetic complications should be
the target goal and quality indicator of DM management
in primary care. The health preference scores of different
DM-related disease states provided in this study would
facilitate the cost-utility or cost-effectiveness studies of
alternative management strategies for prevention of dia-
betic complications in Chinese population.
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